Arrotex Pharmaceuticals, backed by AFR Rich Lister Dennis Bastas, has snapped up Farmaforce from the administrators of failed controversial biotech iQ Group Global.
The administrators at De Vries Tayeh also confirmed that offers had been made for a yacht that the biotechnology outfit had bought for $1.2 million. It was poised to be sold next week, although the potential buyers were not detailed.
Loading...
Carrie LaFrenz is a senior journalist covering retail/consumer goods. She previously covered healthcare/biotech. Carrie has won multiple awards for her journalism including financial journalist of the year from The National Press Club. Connect with Carrie on Twitter. Email Carrie at carrie.lafrenz@afr.com
Liam Walsh writes on investigations and companies with The Australian Financial Review. He has won multiple media awards, worked in Japan and is now based in Brisbane. Email Liam at liam.walsh@afr.com.au
